IN8bio is accelerating patient enrollment in the INB-100 program and expects to complete enrollment of the expansion cohort in 2025. The company’s FDA discussions confirmed that relapse-free survival ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
News Medical on MSN7h
A step toward precision medicine: New drug targets for heart failureA groundbreaking study in Nature Cardiovascular Research uncovers promising drug targets for heart failure (HF) and its ...
It's not unusual for a city to double for another metropolis in movies. New Yorkers have long been able to spot when Toronto has been substituted for the Big Apple. Matthew Rankin, though, has gone ...
Procore Technologies (NYSE:PCOR) reported its Q4 2024 earnings, revealing a mixed financial performance. The company posted an EPS of $0.01, falling short of the expected $0.11. However, revenue ...
Companies on the 2024 Inc. 5000 are ranked according to percentage revenue growth over the last three years. They generated 874,940 jobs, $317 billion in revenue, and show where the economy is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback